Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome
Autor(a) principal: | |
---|---|
Data de Publicação: | 2002 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1210/jcem.87.3.8316 http://repositorio.unifesp.br/handle/11600/26762 |
Resumo: | Polycystic ovary syndrome (PCOS) is a major cause of female infertility. Despite substantial effort, the etiology and pathogenesis of PCOS and polycystic ovaries (PCO) in women remain unknown. Recent studies in laboratory animals have documented a link between dysfunction of two oocyte growth factors, growth differentiation factor-9 (GDF-9) and bone morphogenetic factor-15 (BMP-15), and aberrant folliculogenesis. Because aberrant follicle development is a hallmark of PCOS, we wondered whether the expression patterns of these growth factors might be disrupted in PCOS and PCO oocytes. To address this issue, we compared the pattern and level of expression of GDF-9 and BMP-15 mRNA in ovaries from normal cycling (n = 12), PCOS (n = 5), and PCO (n = 7) patients. in situ hybridization studies showed that the expression of GDF-9 and BMP-15 is restricted to the oocytes in all ovaries examined. Interestingly, a decreased level of GDF-9 signal was observed in developing PCOS and PCO oocytes, compared with normal. This difference was evident throughout folliculogenesis, beginning at recruitment initiation and continuing through the small Graafian follicle stage. By contrast, there were no qualitative or quantitative changes in the expression of BMP-15 mRNA in PCOS oocytes during folliculogenesis. There were also no significant differences between normal and PCOS and PCOs in the levels of the mRNA encoding the housekeeping gene, cyclophilin. Together, these results indicate that the expression of GDF-9 mRNA is delayed and reduced in PCOS and PCO oocytes during their growth and differentiation phase. Because oocyte-derived GDF-9 is crucial for normal folliculogenesis and female fertility, we suggest that a dysregulation of oocyte GDF-9 expression may contribute to aberrant folliculogenesis in PCOS and PCO women. |
id |
UFSP_605d9fc5ed337ebb6e11acf09c029814 |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/26762 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndromePolycystic ovary syndrome (PCOS) is a major cause of female infertility. Despite substantial effort, the etiology and pathogenesis of PCOS and polycystic ovaries (PCO) in women remain unknown. Recent studies in laboratory animals have documented a link between dysfunction of two oocyte growth factors, growth differentiation factor-9 (GDF-9) and bone morphogenetic factor-15 (BMP-15), and aberrant folliculogenesis. Because aberrant follicle development is a hallmark of PCOS, we wondered whether the expression patterns of these growth factors might be disrupted in PCOS and PCO oocytes. To address this issue, we compared the pattern and level of expression of GDF-9 and BMP-15 mRNA in ovaries from normal cycling (n = 12), PCOS (n = 5), and PCO (n = 7) patients. in situ hybridization studies showed that the expression of GDF-9 and BMP-15 is restricted to the oocytes in all ovaries examined. Interestingly, a decreased level of GDF-9 signal was observed in developing PCOS and PCO oocytes, compared with normal. This difference was evident throughout folliculogenesis, beginning at recruitment initiation and continuing through the small Graafian follicle stage. By contrast, there were no qualitative or quantitative changes in the expression of BMP-15 mRNA in PCOS oocytes during folliculogenesis. There were also no significant differences between normal and PCOS and PCOs in the levels of the mRNA encoding the housekeeping gene, cyclophilin. Together, these results indicate that the expression of GDF-9 mRNA is delayed and reduced in PCOS and PCO oocytes during their growth and differentiation phase. Because oocyte-derived GDF-9 is crucial for normal folliculogenesis and female fertility, we suggest that a dysregulation of oocyte GDF-9 expression may contribute to aberrant folliculogenesis in PCOS and PCO women.Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USAUniversidade Federal de São Paulo, BR-01311940 São Paulo, BrazilKyungpook Natl Univ, Taegu 700721, South KoreaSeoul Natl Univ, Coll Med, Seoul 110744, South KoreaUniversidade Federal de São Paulo, BR-01311940 São Paulo, BrazilWeb of ScienceEndocrine SocUniv Calif San DiegoUniversidade Federal de São Paulo (UNIFESP)Kyungpook Natl UnivSeoul Natl UnivTeixeira Filho, Fabio Lopes [UNIFESP]Baracat, Edmund Chada [UNIFESP]Lee, Taek HooSuh, Chang SukMatsui, MotozumiChang, R. JeffreyShimasaki, ShunichiErickson, Gregory F.2016-01-24T12:33:16Z2016-01-24T12:33:16Z2002-03-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion1337-1344http://dx.doi.org/10.1210/jcem.87.3.8316Journal of Clinical Endocrinology & Metabolism. Chevy Chase: Endocrine Soc, v. 87, n. 3, p. 1337-1344, 2002.10.1210/jcem.87.3.83160021-972Xhttp://repositorio.unifesp.br/handle/11600/26762WOS:000174620600060engJournal of Clinical Endocrinology & Metabolisminfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2016-01-24T10:33:16Zoai:repositorio.unifesp.br/:11600/26762Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652016-01-24T10:33:16Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome |
title |
Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome |
spellingShingle |
Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome Teixeira Filho, Fabio Lopes [UNIFESP] |
title_short |
Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome |
title_full |
Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome |
title_fullStr |
Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome |
title_full_unstemmed |
Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome |
title_sort |
Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome |
author |
Teixeira Filho, Fabio Lopes [UNIFESP] |
author_facet |
Teixeira Filho, Fabio Lopes [UNIFESP] Baracat, Edmund Chada [UNIFESP] Lee, Taek Hoo Suh, Chang Suk Matsui, Motozumi Chang, R. Jeffrey Shimasaki, Shunichi Erickson, Gregory F. |
author_role |
author |
author2 |
Baracat, Edmund Chada [UNIFESP] Lee, Taek Hoo Suh, Chang Suk Matsui, Motozumi Chang, R. Jeffrey Shimasaki, Shunichi Erickson, Gregory F. |
author2_role |
author author author author author author author |
dc.contributor.none.fl_str_mv |
Univ Calif San Diego Universidade Federal de São Paulo (UNIFESP) Kyungpook Natl Univ Seoul Natl Univ |
dc.contributor.author.fl_str_mv |
Teixeira Filho, Fabio Lopes [UNIFESP] Baracat, Edmund Chada [UNIFESP] Lee, Taek Hoo Suh, Chang Suk Matsui, Motozumi Chang, R. Jeffrey Shimasaki, Shunichi Erickson, Gregory F. |
description |
Polycystic ovary syndrome (PCOS) is a major cause of female infertility. Despite substantial effort, the etiology and pathogenesis of PCOS and polycystic ovaries (PCO) in women remain unknown. Recent studies in laboratory animals have documented a link between dysfunction of two oocyte growth factors, growth differentiation factor-9 (GDF-9) and bone morphogenetic factor-15 (BMP-15), and aberrant folliculogenesis. Because aberrant follicle development is a hallmark of PCOS, we wondered whether the expression patterns of these growth factors might be disrupted in PCOS and PCO oocytes. To address this issue, we compared the pattern and level of expression of GDF-9 and BMP-15 mRNA in ovaries from normal cycling (n = 12), PCOS (n = 5), and PCO (n = 7) patients. in situ hybridization studies showed that the expression of GDF-9 and BMP-15 is restricted to the oocytes in all ovaries examined. Interestingly, a decreased level of GDF-9 signal was observed in developing PCOS and PCO oocytes, compared with normal. This difference was evident throughout folliculogenesis, beginning at recruitment initiation and continuing through the small Graafian follicle stage. By contrast, there were no qualitative or quantitative changes in the expression of BMP-15 mRNA in PCOS oocytes during folliculogenesis. There were also no significant differences between normal and PCOS and PCOs in the levels of the mRNA encoding the housekeeping gene, cyclophilin. Together, these results indicate that the expression of GDF-9 mRNA is delayed and reduced in PCOS and PCO oocytes during their growth and differentiation phase. Because oocyte-derived GDF-9 is crucial for normal folliculogenesis and female fertility, we suggest that a dysregulation of oocyte GDF-9 expression may contribute to aberrant folliculogenesis in PCOS and PCO women. |
publishDate |
2002 |
dc.date.none.fl_str_mv |
2002-03-01 2016-01-24T12:33:16Z 2016-01-24T12:33:16Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1210/jcem.87.3.8316 Journal of Clinical Endocrinology & Metabolism. Chevy Chase: Endocrine Soc, v. 87, n. 3, p. 1337-1344, 2002. 10.1210/jcem.87.3.8316 0021-972X http://repositorio.unifesp.br/handle/11600/26762 WOS:000174620600060 |
url |
http://dx.doi.org/10.1210/jcem.87.3.8316 http://repositorio.unifesp.br/handle/11600/26762 |
identifier_str_mv |
Journal of Clinical Endocrinology & Metabolism. Chevy Chase: Endocrine Soc, v. 87, n. 3, p. 1337-1344, 2002. 10.1210/jcem.87.3.8316 0021-972X WOS:000174620600060 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Journal of Clinical Endocrinology & Metabolism |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
1337-1344 |
dc.publisher.none.fl_str_mv |
Endocrine Soc |
publisher.none.fl_str_mv |
Endocrine Soc |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268424228962304 |